2 Day Course: The Arab Pharmacovigilance Guidelines - ResearchAndMarkets.com

DUBLIN--()--The "The Arab Pharmacovigilance Guidelines" conference has been added to ResearchAndMarkets.com's offering.

There are fundamental changes to pharmacovigilance practice described in these guidelines which follow the EU guidelines, issued and implemented in June 2012. This intensive two-day course will look at the various new topics and their practical application.

The new Arab pharmacovigilance guidelines were issued in May 2015 with their introduction on 1 July 2015. There are fundamental changes to pharmacovigilance practice described in these guidelines which follow the EU guidelines, issued and implemented in June 2012.

This intensive two-day course will look at the various new topics and their practical application from the perspective of the introduction of the EU guidelines. The course will include experiences of inspections and audits following implementation and will identify what the main focus points will be.

Agenda

Programme - Day One

  • An Introduction to the new PV Structure
  • Module I - Quality management systems
  • The Pharmacovigilance Systems Master File (PSMF - Module II)
  • Pharmacovigilance inspections (Module III)
  • Pharmacovigilance audits (Module IV)

Programme - Day Two

  • Risk Management Plans (RMPs - Module V)
  • Module VI - Adverse Reaction Reporting - Part 1
  • Module VI - Adverse Reaction Reporting - Part 2
  • PSURs/Module VII
  • Signals and their management (Module IX)

For more information about this conference visit https://www.researchandmarkets.com/research/gsnhlp/2_day_course_the?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Discovery

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Discovery